mRNA Flu Vaccine Shows Stronger, Longer-Lasting Immune Response
Moderna’s investigational mRNA flu vaccine generated broader, longer-lasting immune responses than a standard flu shot, potentially improving protection against evolving influenza strains and reducing vaccine mismatch.
The post mRNA Flu Vaccine Shows Stronger, Longer-Lasting Immune Response appeared first on GEN - Genetic Engineering and Biotechnology News.
